XML 59 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of Estimated Useful Life of Assets Based on Depreciation and Amortization Expense Depreciation and amortization expense is recognized using the straight-line method over the estimated useful life of each asset, as follows:

 

 

 

Estimated Useful Life

Building

 

26 years

Furniture and fixtures

 

5 - 7 years

Lab equipment

 

5 years

Computer equipment

 

3 years

Software

 

3 years

Leasehold improvements

 

shorter of the estimated useful life or the lease term

Property and equipment, net consisted of the following:

 

 

 

December 31,

 

 

 

2022

 

 

2021

 

Building(1)

 

$

 

 

$

12,513

 

Leasehold improvements(2)

 

 

70,113

 

 

 

71,468

 

Laboratory and production equipment

 

 

14,433

 

 

 

11,395

 

Machinery, equipment and fixtures

 

 

7,780

 

 

 

7,974

 

Construction in progress

 

 

3,660

 

 

 

2,054

 

Property and equipment

 

 

95,986

 

 

 

105,404

 

Less: Accumulated depreciation and amortization(3)

 

 

(20,331

)

 

 

(14,779

)

Property and equipment, net

 

$

75,655

 

 

$

90,625

 

 

(1)
Includes $12,513 at December 31, 2021 under financing lease resulting from a failed sale leaseback (see Note 11).
(2)
Includes $70,959 at December 31, 2021 under financing lease resulting from a failed sale leaseback (see Note 11).
(3)
Includes $5,971 at December 31, 2021 under financing lease resulting from a failed sale leaseback (see Note 11).
Schedule of Basic and Diluted Net Income (Loss) Per Share A reconciliation of the numerators and denominators of the basic and diluted net income (loss) per share calculations are as follows:

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Numerator:

 

 

 

 

 

 

Net income (loss)

 

$

14,192

 

 

$

(100,118

)

Denominator:

 

 

 

 

 

 

Weighted average shares outstanding, basic

 

 

139,907,029

 

 

 

67,057,278

 

Weighted average dilutive stock options

 

 

9,586,018

 

 

 

 

Weighted average restricted stock units

 

 

336,969

 

 

 

 

Weighted average shares outstanding, diluted

 

 

149,830,016

 

 

 

67,057,278

 

 

 

 

 

 

 

 

Net income (loss), basic

 

$

0.10

 

 

$

(1.49

)

Net income (loss), diluted

 

$

0.09

 

 

$

(1.49

)

Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted-average Shares of Common Stock Outstanding

The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock outstanding, prior to the use of the two-class method, as they would be anti-dilutive:

 

 

 

December 31,

 

 

 

2022

 

 

2021

 

Stock options

 

 

12,392,188

 

 

 

26,533,868

 

Restricted stock units

 

 

1,284,090

 

 

 

474,700

 

Warrants

 

 

33,458,360

 

 

 

42,686,195

 

Convertible debt

 

 

6,291,011

 

 

 

 

 

 

 

53,425,649

 

 

 

69,694,763